Clinical Research News

  • October 07, 2019 – Clinical Trials Research Informatics Office

    We are writing to update you on the status of the clinical research support processes in the DF/HCC Office for Human Research Studies (OHRS). While we all recognize the mission-critical importance of reviewing clinical...

  • October 03, 2019 – Clinical Trials Research Informatics Office

    If you have deposited genomic data into dbGaP, you received an email from the NIH with the subject line: ACTION NEEDED: Update to NIH Access Procedures for Genomic Summary Results. The email requested action by May 1,...

  • August 01, 2019 – ODQ

    Recent updates to DF/HCC Policies and Operations are effective as of August 1st - See a summary of changes here...

  • May 28, 2019 – ODQ

    As part of the transition to iRIS, we will begin to phase out the posting of Front Sheets in OncPro. The information currently captured on the front sheets is available to research staff in OnCore. Much of the same...

  • May 13, 2019 – PRMS

    Coming in July, 2019, the iRIS system will help accomplish our goal to enhance the entire submission process, and be able to activate trials faster for our patients. Over the next 2 months, we will be providing...

  • March 08, 2019 – Office for Human Research Studies

    In response to feedback regarding the OHRS Verification Process, OHRS has designed a more efficient and collaborative verification request process. After consulting with your institutional technology transfer or...

  • February 19, 2019 – Office for Human Research Studies

    The revised policy formally acknowledges that partners of participants are not DF/HCC research participants and should not be consented by DF/HCC investigators; any request for data collection from pregnant partners...

  • January 30, 2019 – Office for Human Research Studies

    In preparation for the upcoming implementation of the new PRMS system (iRIS), protocol and amendment activation will transition from OHRS to ODQ on February 4, 2019. I am writing to give you a heads up about this change...

  • December 06, 2018 – Office for Human Research Studies

    The DFCI IRB has acknowledged a nationwide shortage of Diphenhydramine Injection (IV Benadryl) and has determined that the shortage is not considered serious or continuing non-compliance or an unanticipated problem...

  • December 04, 2018 – Office for Human Research Studies

    In 2017, the FDA announced that they have further streamlined the expanded access process by updating the Form 3926 to allow for a waiver of the requirement for review and approval at a convened IRB meeting. As a...

  • Older Newer